Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoluo Pills is a traditional Chinese medicine (TCM) formulation primarily used for the treatment of rheumatoid arthritis (RA) and other musculoskeletal disorders characterized by 'Wind-Damp' or 'Cold-Damp' obstruction according to TCM theory. The formulation typically consists of several herbal and animal-derived ingredients, including processed *Radix Aconiti* (Chuan Wu), *Radix Aconiti Kusnezoffii* (Cao Wu), *Arisaema Cum Bile* (Dan Nan Xing), *Lumbricus* (Di Long), *Olibanum* (Ru Xiang), and *Myrrha* (Mo Yao). Huoluo Pills are designed to dispel wind, eliminate dampness, resolve phlegm, and unblock the body's collaterals to alleviate pain and joint stiffness. Pharmacologically, the constituents of the pills have been shown to exert anti-inflammatory, analgesic, and immunomodulatory effects by suppressing the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, as well as inhibiting the activity of enzymes like COX-2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoluo Pills.